Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Sarepta Therapeutics Inc Note 1.250 9/1
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Wells Fargo & Company
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $889k | 875k | 1.02 |
2023-09-30 | $510k | 455k | 1.12 |
Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1
View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1